Teva And mAbxience Join Forces On Unnamed Oncology Biosimilar

Israeli Firm Continues Partnership Model; mAbxience Aligns With Another Major Firm

 
• By Dean Rudge
  
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products